What You Should Know:
– Aegis Ventures, a prominent venture studio based in New York, announced today that Murray Brozinsky has joined its leadership team as a Partner.
– Brozinsky brings a wealth of experience in launching, leading, and successfully exiting several health technology companies, including Healthline, Talix, and Conversa Health.
A Track Record of Success in Healthcare Technology
As the CEO of Conversa Health, Brozinsky steered the company through the challenges of COVID-19, achieving hypergrowth and successfully merging with Amwell, a leading hybrid care enablement platform. Under his leadership, Conversa Health garnered numerous accolades, including recognition as the Best Remote Diagnostics Company, Leading AI-Chatbot for Self-Triage, and Best Patient Engagement Solution. Brozinsky himself was named one of the
Top 50 Healthcare Technology CEOs in both 2022 and 2021.
Strategic Expansion and Growth at Aegis Ventures
Brozinsky joins Aegis Ventures at a pivotal time of expansion and growth as the company pursues its mission of leveraging advanced technologies to transform healthcare in collaboration with leading American healthcare systems. His addition to the leadership team follows the recent launch of the Aegis Digital Consortium, a strategic alliance of nine prominent regional healthcare systems that partner with Aegis to co-develop, invest in, and deploy healthtech solutions aimed at addressing the most pressing challenges in healthcare.
“I’m passionate about creating companies at the intersection of compassion and computation, working with like-minded people to build purpose-built solutions that improve lives,” said Brozinsky. “Healthcare is at the precipice of a profound transformation from reactive to proactive care, fueled by recent advancements in AI. Aegis is in the vanguard of this revolution, uniquely listening to and partnering with health systems to inform how we can best use technology to re-envision health and care. I’m excited to join the Aegis team to help grow and co-create the next cohort of game-changing healthtech companies.”
